{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:10:04Z","timestamp":1793106604729,"version":"4.5.0"},"reference-count":138,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ram\u00f3n y Cajal fellowship","award":["RYC2021-034267-I"],"award-info":[{"award-number":["RYC2021-034267-I"]}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PID2022-139936OA-I00"],"award-info":[{"award-number":["PID2022-139936OA-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Complutense University of Madrid-Banco Santander","award":["CT25\/24"],"award-info":[{"award-number":["CT25\/24"]}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Neurodegeneration is intrinsically linked to aging through processes such as oxidative stress, mitochondrial dysfunction, and chronic inflammation. Nuclear factor erythroid 2-related factor 2 (Nrf2) emerges as a central transcription factor regulating these molecular events and promoting cytoprotective responses. In neurodegenerative diseases, notably, frontotemporal dementia (FTD) and Parkinson\u2019s disease (PD), genetic mutations\u2014including MAPT, LRRK2, PINK1, PRKN, and SNCA\u2014have been reported to alter Nrf2 signaling, both in vitro and in vivo. Melatonin, a neurohormone widely known for its strong antioxidant and mitochondria-stabilizing properties, has been shown to activate Nrf2 and restore redox balance in several experimental models of neurodegeneration. Its effects include a reduction in tau hyperphosphorylation, \u03b1-synuclein aggregation, and neuroinflammation. While most data are derived from sporadic models of Alzheimer\u2019s disease and PD, emerging evidence supports a role for melatonin in familial forms of FTD and PD as well. Thus, targeting Nrf2 through melatonin may offer a promising approach to mitigating neurodegeneration, especially in the context of mutation-driven pathologies. Further investigation is warranted to explore mutation-specific responses and optimize the therapeutic strategies.<\/jats:p>","DOI":"10.3390\/antiox14101190","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:00:32Z","timestamp":1759132832000},"page":"1190","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Melatonin-Mediated Nrf2 Activation as a Potential Therapeutic Strategy in Mutation-Driven Neurodegenerative Diseases"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6039-3183","authenticated-orcid":false,"given":"Luc\u00eda","family":"\u00cd\u00f1igo-Catalina","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7725-6380","authenticated-orcid":false,"given":"Mar\u00eda","family":"Ortiz-Cabello","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Navarro","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain"},{"name":"Neurochemistry Research Institute, Complutense University of Madrid, 28040 Madrid, Spain"},{"name":"CIBERNED (Network Center for Biomedical Research in Neurodegenerative Diseases), 28029 Madrid, Spain"},{"name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS), 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7938-6131","authenticated-orcid":false,"given":"Noem\u00ed","family":"Esteras","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain"},{"name":"Neurochemistry Research Institute, Complutense University of Madrid, 28040 Madrid, Spain"},{"name":"CIBERNED (Network Center for Biomedical Research in Neurodegenerative Diseases), 28029 Madrid, Spain"},{"name":"Group of Neurodegenerative Diseases, Hospital Universitario 12 de Octubre Research Institute (imas12), 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1556-192X","authenticated-orcid":false,"given":"Lisa","family":"Rancan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4646-4199","authenticated-orcid":false,"given":"Sergio D.","family":"Paredes","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"111837","DOI":"10.1016\/j.mad.2023.111837","article-title":"Aging\u2014What It Is and How to Measure It","volume":"213","author":"Keshavarz","year":"2023","journal-title":"Mech. Ageing Dev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.tig.2023.08.005","article-title":"The Evolution of Aging and Lifespan","volume":"39","author":"Li","year":"2023","journal-title":"Trends Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The Hallmarks of Aging","volume":"153","author":"Blasco","year":"2013","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of Aging: An Expanding Universe","volume":"186","author":"Blasco","year":"2023","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Hajam, Y.A., Rani, R., Ganie, S.Y., Sheikh, T.A., Javaid, D., Qadri, S.S., Pramodh, S., Alsulimani, A., Alkhanani, M.F., and Harakeh, S. (2022). Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives. Cells, 11.","DOI":"10.3390\/cells11030552"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2105607","DOI":"10.1155\/2019\/2105607","article-title":"Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View","volume":"2019","author":"Cenini","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1089\/dna.2019.5347","article-title":"Mitochondrial and Nuclear DNA Oxidative Damage in Physiological and Pathological Aging","volume":"39","author":"Kowalska","year":"2020","journal-title":"DNA Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Misrani, A., Tabassum, S., and Yang, L. (2021). Mitochondrial Dysfunction and Oxidative Stress in Alzheimer\u2019s Disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.617588"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/1873-3468.12902","article-title":"The Role of Mitochondrial ROS in the Aging Brain","volume":"592","author":"Stefanatos","year":"2018","journal-title":"FEBS Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/ars.2012.4774","article-title":"Mitochondrial Energy Metabolism and Redox Signaling in Brain Aging and Neurodegeneration","volume":"20","author":"Yin","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of Neurodegenerative Diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","article-title":"Nrf2-ARE Pathway: An Emerging Target against Oxidative Stress and Neuroinflammation in Neurodegenerative Diseases","volume":"157","author":"Buendia","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mayer, C., Riera-Ponsati, L., Kauppinen, S., Klitgaard, H., Erler, J.T., and Hansen, S.N. (2024). Targeting the NRF2 Pathway for Disease Modification in Neurodegenerative Diseases: Mechanisms and Therapeutic Implications. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1437939"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41576-019-0183-6","article-title":"The Genetics of Human Ageing","volume":"21","author":"Melzer","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Azam, S., Haque, M.E., Balakrishnan, R., Kim, I.-S., and Choi, D.-K. (2021). The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.683459"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tem.2022.01.007","article-title":"Targeting Aging Mechanisms: Pharmacological Perspectives","volume":"33","author":"Moskalev","year":"2022","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sadowska-Bartosz, I., and Bartosz, G. (2014). Effect of Antioxidants Supplementation on Aging and Longevity. BioMed Res. Int., 2014.","DOI":"10.1155\/2014\/404680"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Minich, D.M., Henning, M., Darley, C., Fahoum, M., Schuler, C.B., and Frame, J. (2022). Is Melatonin the \u201cNext Vitamin D\u201d?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements. Nutrients, 14.","DOI":"10.3390\/nu14193934"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Navarro, E., and Esteras, N. (2024). Multitarget Effects of Nrf2 Signalling in the Brain: Common and Specific Functions in Different Cell Types. Antioxidants, 13.","DOI":"10.20944\/preprints202411.1766.v1"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Vomund, S., Sch\u00e4fer, A., Parnham, M.J., Br\u00fcne, B., and von Knethen, A. (2017). Nrf2, the Master Regulator of Anti-Oxidative Responses. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122772"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e00099-20","DOI":"10.1128\/MCB.00099-20","article-title":"The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6635460","DOI":"10.1155\/2021\/6635460","article-title":"The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging","volume":"2021","author":"Yu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1177\/1060028013509232","article-title":"Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis","volume":"47","author":"Venci","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13023-024-03474-6","article-title":"Safety and Efficacy of Omaveloxolone v\/s Placebo for the Treatment of Friedreich\u2019s Ataxia in Patients Aged More than 16 Years: A Systematic Review","volume":"19","author":"Umrao","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/nen.0b013e31802d6da9","article-title":"Expression of Nrf2 in Neurodegenerative Diseases","volume":"66","author":"Ramsey","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.mcn.2008.07.010","article-title":"Nuclear Factor Erythroid 2-Related Factor 2 Protects against Beta Amyloid","volume":"39","author":"Kanninen","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1093\/hmg\/dds143","article-title":"\u03b1-Synuclein Expression and Nrf2 Deficiency Cooperate to Aggravate Protein Aggregation, Neuronal Death and Inflammation in Early-Stage Parkinson\u2019s Disease","volume":"21","author":"Ulusoy","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.neurobiolaging.2003.12.010","article-title":"Expression of NAD(P)H:Quinone Oxidoreductase in the Normal and Parkinsonian Substantia Nigra","volume":"25","author":"Bol","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-Mediated Neuroprotection in the MPTP Mouse Model of Parkinson\u2019s Disease: Critical Role for the Astrocyte","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Innamorato, N.G., Jazwa, A., Rojo, A.I., Garc\u00eda, C., Fern\u00e1ndez-Ruiz, J., Grochot\u2013Przeczek, A., Stachurska, A., Jozkowicz, A., Dulak, J., and Cuadrado, A. (2010). Different Susceptibility to the Parkinson\u2019s Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011838"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Buttari, B., Tramutola, A., Rojo, A.I., Chondrogianni, N., Saha, S., Berry, A., Giona, L., Miranda, J.P., Profumo, E., and Davinelli, S. (2025). Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2. Biomolecules, 15.","DOI":"10.3390\/biom15010113"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/bio.20134853","article-title":"Nrf2 Impacts Cellular Bioenergetics by Controlling Substrate Availability for Mitochondrial Respiration","volume":"2","author":"Baird","year":"2013","journal-title":"Biol. Open"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2015.04.036","article-title":"The Emerging Role of Nrf2 in Mitochondrial Function","volume":"88","author":"Abramov","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Villavicencio Tejo, F., and Quintanilla, R.A. (2021). Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer\u2019s Disease. Antioxidants, 10.","DOI":"10.3390\/antiox10071069"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gureev, A.P., Shaforostova, E.A., and Popov, V.N. (2019). Regulation of Mitochondrial Biogenesis as a Way for Active Longevity: Interaction Between the Nrf2 and PGC-1\u03b1 Signaling Pathways. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.00435"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/MCB.00248-10","article-title":"A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and P62","volume":"30","author":"Lau","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cotox.2016.10.002","article-title":"The Multifaceted Role of Nrf2 in Mitochondrial Function","volume":"1","author":"Kostov","year":"2016","journal-title":"Curr. Opin. Toxicol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","article-title":"Frontotemporal Dementia","volume":"35","author":"Olney","year":"2017","journal-title":"Neurol. Clin."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Esteras, N., and Abramov, A.Y. (2020). Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology. Cells, 9.","DOI":"10.3390\/cells9092135"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Fl\u00f8nes, I.H., and Tzoulis, C. (2022). Mitochondrial Respiratory Chain Dysfunction\u2014A Hallmark Pathology of Idiopathic Parkinson\u2019s Disease?. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.874596"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41531-023-00564-3","article-title":"Parkinson\u2019s Disease Neurons Exhibit Alterations in Mitochondrial Quality Control Proteins","volume":"9","author":"Chen","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1167\/iovs.11-8717","article-title":"Effect of Circadian Clock Gene Mutations on Nonvisual Photoreception in the Mouse","volume":"53","author":"Owens","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_44","first-page":"604","article-title":"Melatonin: The first hormone isolated from the pineal body","volume":"13","author":"Alberti","year":"1958","journal-title":"Il Farm. Ed. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ja01543a060","article-title":"Isolation of Melatonin, the Pineal Gland Factor That Lightens Melanocytes","volume":"80","author":"Lerner","year":"1958","journal-title":"J. Am. Chem. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mineiro, R., Rodrigues Cardoso, M., Catarina Duarte, A., Santos, C., Cipolla-Neto, J., Gaspar do Amaral, F., Costa, D., and Quintela, T. (2024). Melatonin and Brain Barriers: The Protection Conferred by Melatonin to the Blood-Brain Barrier and Blood-Cerebrospinal Fluid Barrier. Front. Neuroendocrinol., 75.","DOI":"10.1016\/j.yfrne.2024.101158"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","article-title":"Extrapineal Melatonin: Sources, Regulation, and Potential Functions","volume":"71","author":"Escames","year":"2014","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-079X.2000.280401.x","article-title":"Evidence for Melatonin Synthesis in Mouse and Human Bone Marrow Cells","volume":"28","author":"Conti","year":"2000","journal-title":"J. Pineal Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"G623","DOI":"10.1152\/ajpgi.00118.2011","article-title":"Melatonin Exerts by an Autocrine Loop Antiproliferative Effects in Cholangiocarcinoma; Its Synthesis Is Reduced Favoring Cholangiocarcinoma Growth","volume":"301","author":"Han","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Kopustinskiene, D.M., and Bernatoniene, J. (2021). Molecular Mechanisms of Melatonin-Mediated Cell Protection and Signaling in Health and Disease. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020129"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1152\/physiol.00011.2014","article-title":"Melatonin: Exceeding Expectations","volume":"29","author":"Reiter","year":"2014","journal-title":"Physiology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12640-014-9489-5","article-title":"Melatonin Antagonizes Mn-Induced Oxidative Injury Through the Activation of Keap1\u2013Nrf2\u2013ARE Signaling Pathway in the Striatum of Mice","volume":"27","author":"Deng","year":"2015","journal-title":"Neurotox. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e70008","DOI":"10.1111\/jpi.70008","article-title":"Protective Activity of Melatonin Combinations and Melatonin-Based Hybrid Molecules in Neurodegenerative Diseases","volume":"76","author":"Galvani","year":"2024","journal-title":"J. Pineal Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14496","DOI":"10.1523\/JNEUROSCI.3059-11.2011","article-title":"The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity","volume":"31","author":"Wang","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mce.2014.12.013","article-title":"The Keap1-Nrf2-Antioxidant Response Element Pathway: A Review of Its Regulation by Melatonin and the Proteasome","volume":"401","author":"Vriend","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Reiter, R.J., Tan, D.X., Rosales-Corral, S., Galano, A., Jou, M.-J., and Acuna-Castroviejo, D. (2018). Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082439"},{"key":"ref_57","first-page":"3542","article-title":"Protective Effects of Melatonin on Mitochondrial Biogenesis and Mitochondrial Structure and Function in the HEK293-APPswe Cell Model of Alzheimer\u2019s Disease","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e70285","DOI":"10.1111\/jcmm.70285","article-title":"Melatonin Reduces Mito-Inflammation in Ischaemic Hippocampal HT22 Cells and Modulates the cGAS\u2013STING Cytosolic DNA Sensing Pathway and FGF21 Release","volume":"28","author":"Carloni","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e70037","DOI":"10.1111\/jpi.70037","article-title":"Melatonin Deficits Result in Pathologic Metabolic Reprogramming in Differentiated Neurons","volume":"77","author":"Jauhari","year":"2025","journal-title":"J. Pineal Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-079X.2006.00412.x","article-title":"Melatonin Protects against Rotenone-Induced Oxidative Stress in a Hemiparkinsonian Rat Model","volume":"42","author":"Saravanan","year":"2007","journal-title":"J. Pineal Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Costa, M.F.D., R\u00f6sler, T.W., and H\u00f6glinger, G.U. (2024). Exploring the Neuroprotective Potential of Nrf2-Pathway Activators against Annonacin Toxicity. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-70837-1"},{"key":"ref_62","first-page":"947","article-title":"Add-on Prolonged-Release Melatonin for Cognitive Function and Sleep in Mild&nbsp;to Moderate Alzheimer&rsquo;s Disease: A 6-Month, Randomized, Placebo-Controlled, Multicenter Trial","volume":"9","author":"Wade","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"ref_63","unstructured":"Savage, R.A., Zafar, N., Yohannan, S., and Miller, J.-M.M. (2025). Melatonin. StatPearls, StatPearls Publishing."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/00912700022009422","article-title":"The Absolute Bioavailability of Oral Melatonin","volume":"40","author":"DeMuro","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5664\/jcsm.6434","article-title":"Poor Quality Control of Over-the-Counter Melatonin: What They Say Is Often Not What You Get","volume":"13","author":"Ianakieva","year":"2017","journal-title":"J. Clin. Sleep Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/abbi.1999.1404","article-title":"Increased Neuronal Glucose-6-Phosphate Dehydrogenase and Sulfhydryl Levels Indicate Reductive Compensation to Oxidative Stress in Alzheimer Disease","volume":"370","author":"Russell","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"117542","DOI":"10.1016\/j.ecoenv.2024.117542","article-title":"The Ameliorative Effects of Melatonin against BDE-47-Induced Hippocampal Neuronal Ferroptosis and Cognitive Dysfunction through Nrf2-Chaperone-Mediated Autophagy of ACSL4 Degradation","volume":"290","author":"Yuan","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in Oxidative Stress and Toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/ars.2024.0586","article-title":"Adverse Effects of Nrf2 in Different Organs and the Related Diseases","volume":"42","author":"Jin","year":"2025","journal-title":"Antioxid. Redox Signal."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","article-title":"MAPT Mutations, Tauopathy, and Mechanisms of Neurodegeneration","volume":"99","author":"Strang","year":"2019","journal-title":"Lab. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbadis.2004.08.009","article-title":"Regulation of Tau Isoform Expression and Dementia","volume":"1739","author":"Schellenberg","year":"2005","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/09540261.2013.776523","article-title":"The Epidemiology of Frontotemporal Dementia","volume":"25","author":"Onyike","year":"2013","journal-title":"Int. Rev. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.celrep.2016.03.068","article-title":"A Polymorphic Antioxidant Response Element Links NRF2\/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders","volume":"15","author":"Wang","year":"2016","journal-title":"Cell Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5114\/fn.2020.100068","article-title":"Inhibition of MAPT Enhances the Effect of Bexarotene and Attenuates the Damage after Traumatic Brain Injury Using in Vivo and in Vitro Experiments","volume":"58","author":"Dong","year":"2020","journal-title":"Folia Neuropathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","article-title":"Transcription Factor NFE2L2\/NRF2 Is a Regulator of Macroautophagy Genes","volume":"12","author":"Pajares","year":"2016","journal-title":"Autophagy"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1038\/ncomms4496","article-title":"Nrf2 Reduces Levels of Phosphorylated Tau Protein by Inducing Autophagy Adaptor Protein NDP52","volume":"5","author":"Jo","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.redox.2017.10.010","article-title":"Pharmacological Targeting of GSK-3 and NRF2 Provides Neuroprotection in a Preclinical Model of Tauopathy","volume":"14","author":"Cuadrado","year":"2018","journal-title":"Redox Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s11357-023-00760-2","article-title":"Effect of Nrf2 Loss on Senescence and Cognition of Tau-Based P301S Mice","volume":"45","author":"Riordan","year":"2023","journal-title":"GeroScience"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12950-024-00396-9","article-title":"Impairment of Nrf2 Signaling in the Hippocampus of P301S Tauopathy Mice Model Aligns with the Cognitive Impairment and the Associated Neuroinflammation","volume":"21","author":"Mohamed","year":"2024","journal-title":"J. Inflamm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e1003","DOI":"10.1002\/ctm2.1003","article-title":"P301S-hTau Acetylates KEAP1 to Trigger Synaptic Toxicity via Inhibiting NRF2\/ARE Pathway: A Novel Mechanism Underlying hTau-induced Synaptic Toxicities","volume":"12","author":"Xie","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1093\/hmg\/ddy201","article-title":"Benfotiamine Treatment Activates the Nrf2\/ARE Pathway and Is Neuroprotective in a Transgenic Mouse Model of Tauopathy","volume":"27","author":"Tapias","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Castro-S\u00e1nchez, S., Garc\u00eda-Yag\u00fce, \u00c1.J., K\u00fcgler, S., and Lastres-Becker, I. (2019). CX3CR1-Deficient Microglia Shows Impaired Signalling of the Transcription Factor NRF2: Implications in Tauopathies. Redox Biol., 22.","DOI":"10.1016\/j.redox.2019.101118"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41467-021-27702-w","article-title":"Reactive Astrocytes Acquire Neuroprotective as Well as Deleterious Signatures in Response to Tau and A\u00df Pathology","volume":"13","author":"Jiwaji","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1750-3639.2007.00052.x","article-title":"Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations","volume":"17","author":"Swieten","year":"2007","journal-title":"Brain Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Schwab, K., Melis, V., Harrington, C.R., Wischik, C.M., Magbagbeolu, M., Theuring, F., and Riedel, G. (2021). Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks. Cells, 10.","DOI":"10.3390\/cells10082162"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Chang, W.-H., Chen, M.C., and Cheng, I.H. (2015). Antroquinonol Lowers Brain Amyloid-\u03b2 Levels and Improves Spatial Learning and Memory in a Transgenic Mouse Model of Alzheimer\u2019s Disease. Sci. Rep., 5.","DOI":"10.1038\/srep15067"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"100435","DOI":"10.1016\/j.bbih.2022.100435","article-title":"Antroquinonol Administration in Animal Preclinical Studies for Alzheimer\u2019s Disease (AD): A New Avenue for Modifying Progression of AD Pathophysiology","volume":"21","author":"Francesca","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kim, J. (2021). Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062929"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3233\/JAD-200896","article-title":"Benfotiamine and Cognitive Decline in Alzheimer\u2019s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial","volume":"78","author":"Gibson","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.36922\/jcbp.1174","article-title":"Use of Melatonin for the Treatment of Dementia: Addressing Core Symptoms and Behavioral Challenges","volume":"1","author":"Masahiro","year":"2023","journal-title":"J. Clin. Basic Psychosom."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41380-024-02691-6","article-title":"Melatonin: A Potential Nighttime Guardian against Alzheimer\u2019s","volume":"30","author":"Zhang","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1759091420981204","DOI":"10.1177\/1759091420981204","article-title":"Melatonin Reduces GSK3\u03b2-Mediated Tau Phosphorylation, Enhances Nrf2 Nuclear Translocation and Anti-Inflammation","volume":"12","author":"Das","year":"2020","journal-title":"ASN Neuro"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-019-0578-9","article-title":"Nrf2 Activation through the PI3K\/GSK-3 Axis Protects Neuronal Cells from A\u03b2-Mediated Oxidative and Metabolic Damage","volume":"12","author":"Sotolongo","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e36921","DOI":"10.1016\/j.heliyon.2024.e36921","article-title":"Melatonin Rescues Pregnant Female Mice and Their Juvenile Offspring from High Fat Diet-Induced Alzheimer Disease Neuropathy","volume":"10","author":"Jan","year":"2024","journal-title":"Heliyon"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"G\u00e1ll, Z., Boros, B., Kelemen, K., Urkon, M., Zolcseak, I., M\u00e1rton, K., and Kolcsar, M. (2024). Melatonin Improves Cognitive Dysfunction and Decreases Gliosis in the Streptozotocin-Induced Rat Model of Sporadic Alzheimer\u2019s Disease. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1447757"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Liu, P., Cheng, M., Guo, J., Cao, D., Luo, J., Wan, Y., Fang, Y., Jin, Y., Xie, S.-S., and Liu, J. (2023). Dual Functional Antioxidant and Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer\u2019s Disease: Design, Synthesis and Evaluation of Novel Melatonin-Alkylbenzylamine Hybrids. Bioorg. Med. Chem., 78.","DOI":"10.1016\/j.bmc.2022.117146"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Zhao, H., Feng, L., Zhong, W., Zhen, H., Chi, Q., and Wang, X. (2021). Hyperphosphorylation of Tau Due to the Interference of Protein Phosphatase Methylesterase-1 Overexpression by MiR-125b-5p in Melatonin Receptor Knockout Mice. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111850"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"20615","DOI":"10.1039\/D1CP03142B","article-title":"Mechanisms of Melatonin Binding and Destabilizing the Protofilament and Filament of Tau R3\u2013R4 Domains Revealed by Molecular Dynamics Simulation","volume":"23","author":"Zhu","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Rong, K., Zheng, H., Yang, R., Liu, X., Li, L., Chen, N., Zhao, G., Gong, C., and Deng, Y. (2020). Melatonin and Its Metabolite N (1)-acetyl- N (1)-formyl-5-methoxykynuramine Improve Learning and Memory Impairment Related to Alzheimer\u2019s Disease in Rats. J. Biochem. Mol. Toxicol., 34.","DOI":"10.1002\/jbt.22430"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pneurobio.2015.07.003","article-title":"Protein Aggregation and Neurodegeneration in Prototypical Neurodegenerative Diseases: Examples of Amyloidopathies, Tauopathies and Synucleinopathies","volume":"155","author":"Bourdenx","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00018-024-05262-8","article-title":"PRKN-Linked Familial Parkinson\u2019s Disease: Cellular and Molecular Mechanisms of Disease-Linked Variants","volume":"81","author":"Clausen","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Vizziello, M., Borellini, L., Franco, G., and Ardolino, G. (2021). Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson\u2019s Disease. Cells, 10.","DOI":"10.3390\/cells10113022"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2174\/1570159X16666180222165418","article-title":"The Role of LRRK2 in Neurodegeneration of Parkinson Disease","volume":"16","author":"Rui","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Repici, M., and Giorgini, F. (2019). DJ-1 in Parkinson\u2019s Disease: Clinical Insights and Therapeutic Perspectives. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091377"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Siddiqui, I.J., Pervaiz, N., and Abbasi, A.A. (2016). The Parkinson Disease Gene SNCA: Evolutionary and Structural Insights with Pathological Implication. Sci. Rep., 6.","DOI":"10.1038\/srep24475"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.09.015","article-title":"\u03b1-Syn Overexpression, NRF2 Suppression, and Enhanced Ferroptosis Create a Vicious Cycle of Neuronal Loss in Parkinson\u2019s Disease","volume":"192","author":"Anandhan","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"14280","DOI":"10.1073\/pnas.1900576116","article-title":"Axonal Pathology in hPSC-Based Models of Parkinson\u2019s Disease Results from Loss of Nrf2 Transcriptional Activity at the Map1b Gene Locus","volume":"116","author":"Czaniecki","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"964","DOI":"10.14336\/AD.2021.0511","article-title":"NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human \u03b1-Synuclein Overexpressing Mice","volume":"12","author":"Anandhan","year":"2021","journal-title":"Aging Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"eadi9018","DOI":"10.1126\/scisignal.adi9018","article-title":"Proximity Proteomic Analysis of the NRF Family Reveals the Parkinson\u2019s Disease Protein ZNF746\/PARIS as a Co-Complexed Repressor of NRF2","volume":"16","author":"LaPak","year":"2023","journal-title":"Sci. Signal."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Sheng, X.-J., Tu, H.-J., Chien, W.-L., Kang, K.-H., Lu, D.-H., Liou, H.-H., Lee, M.-J., and Fu, W.-M. (2017). Antagonism of Proteasome Inhibitor-Induced Heme Oxygenase-1 Expression by PINK1 Mutation. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183076"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Murata, H., Takamatsu, H., Liu, S., Kataoka, K., Huh, N.-H., and Sakaguchi, M. (2015). NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142438"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1248\/bpb.b22-00356","article-title":"Nrf2 Expression Is Decreased in LRRK2 Transgenic Mouse Brain and LRRK2 Overexpressing SH-SY5Y Cells","volume":"46","author":"Kawakami","year":"2023","journal-title":"Biol. Pharm. Bull."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Kim, J., Daadi, E.W., Daadi, E.S., Oh, T., Deleidi, M., and Daadi, M.M. (2023). LRRK2 Attenuates Antioxidant Response in Familial Parkinson\u2019s Disease Derived Neural Stem Cells. Cells, 12.","DOI":"10.3390\/cells12212550"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Banerjee, R., Raj, A., Potdar, C., Pal, P.K., Yadav, R., Kamble, N., Holla, V., and Datta, I. (2023). Astrocytes Differentiated from LRRK2-I1371V Parkinson\u2019s-Disease-Induced Pluripotent Stem Cells Exhibit Similar Yield but Cell-Intrinsic Dysfunction in Glutamate Uptake and Metabolism, ATP Generation, and Nrf2-Mediated Glutathione Machinery. Cells, 12.","DOI":"10.3390\/cells12121592"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Weindel, C.G., Ellzey, L.M., Coleman, A.K., Patrick, K.L., and Watson, R.O. (2024). LRRK2 Kinase Activity Restricts NRF2-Dependent Mitochondrial Protection in Microglia. BioRxiv Prepr. Serv. Biol.","DOI":"10.1101\/2024.07.09.602769"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12974-023-02776-z","article-title":"PARK7\/DJ-1 in Microglia: Implications in Parkinson\u2019s Disease and Relevance as a Therapeutic Target","volume":"20","author":"Scafidi","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41531-024-00851-7","article-title":"Park7 Deletion Leads to Sex-Specific Transcriptome Changes Involving NRF2-CYP1B1 Axis in Mouse Midbrain Astrocytes","volume":"11","author":"Helgueta","year":"2025","journal-title":"npj Park. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Brunialti, E., Villa, A., Toffoli, M., Lucas Del Pozo, S., Rizzi, N., Meda, C., Maggi, A., Schapira, A.H.V., and Ciana, P. (2023). Sex-Specific Microglial Responses to Glucocerebrosidase Inhibition: Relevance to GBA1-Linked Parkinson\u2019s Disease. Cells, 12.","DOI":"10.3390\/cells12030343"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jpi.12332","article-title":"Melatonin Rescues Zebrafish Embryos from the Parkinsonian Phenotype Restoring the Parkin\/PINK1\/DJ-1\/MUL1 Network","volume":"61","author":"Lima","year":"2016","journal-title":"J. Pineal Res."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Aranda-Mart\u00ednez, P., Fern\u00e1ndez-Mart\u00ednez, J., Ram\u00edrez-Casas, Y., Rodr\u00edguez-Santana, C., Rusanova, I., Escames, G., and Acu\u00f1a-Castroviejo, D. (2023). Chronodisruption and Loss of Melatonin Rhythm, Associated with Alterations in Daily Motor Activity and Mitochondrial Dynamics in Parkinsonian Zebrafish, Are Corrected by Melatonin Treatment. Antioxidants, 12.","DOI":"10.3390\/antiox12040954"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.1523\/JNEUROSCI.0979-08.2008","article-title":"Loss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish","volume":"28","author":"Anichtchik","year":"2008","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/0113894501284110240426074746","article-title":"Therapeutic Effects of Melatonin in the Regulation of Ferroptosis: A Review of Current Evidence","volume":"25","author":"Pourhanifeh","year":"2024","journal-title":"Curr. Drug Targets"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e12948","DOI":"10.1111\/jpi.12948","article-title":"Melatonin MT1 Receptors Regulate the Sirt1\/Nrf2\/Ho-1\/Gpx4 Pathway to Prevent \u03b1-Synuclein-Induced Ferroptosis in Parkinson\u2019s Disease","volume":"76","author":"Lv","year":"2024","journal-title":"J. Pineal Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/15548627.2015.1082020","article-title":"Melatonin Attenuates MPTP-Induced Neurotoxicity via Preventing CDK5-Mediated Autophagy and SNCA\/\u03b1-Synuclein Aggregation","volume":"11","author":"Su","year":"2015","journal-title":"Autophagy"},{"key":"ref_125","first-page":"999","article-title":"Melatonin Prevents Dopaminergic Cell Loss Induced by Lentiviral Vectors Expressing A30P Mutant Alpha-Synuclein","volume":"28","author":"Baekelandt","year":"2013","journal-title":"Histol. Histopathol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Dao, J.-J., Zhang, W., Liu, C., Li, Q., Qiao, C.-M., Cui, C., Shen, Y.-Q., Chen, S.-X., and Zhao, W.-J. (2025). Targeted ErbB4 Receptor Activation Prevents D-Galactose-Induced Neuronal Senescence via Inhibiting Ferroptosis Pathway. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1528604"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1021\/acsami.3c17092","article-title":"Melatonin-Loaded Nanoparticles Augment Mitophagy to Retard Parkinson\u2019s Disease","volume":"16","author":"Biswal","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","article-title":"Melatonin Reduces the Neuronal Loss, Downregulation of Dopamine Transporter, and Upregulation of D2 Receptor in Rotenone-Induced Parkinsonian Rats","volume":"44","author":"Lin","year":"2008","journal-title":"J. Pineal Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018025666","article-title":"Melatonin Improves Behavioral and Biochemical Outcomes in a Rotenone-Induced Rat Model of Parkinson\u2019s Disease","volume":"37","author":"Rasheed","year":"2018","journal-title":"J. Environ. Pathol. Toxicol. Oncol. Off. Organ. Int. Soc. Environ. Toxicol. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Kato, Y., Sato, K., Nagamine, H., Kanatani, M., Horikoshi, Y., and Nakaso, K. (2025). Cytoprotective Effect of Melatonin against MPP+ Toxicity in SH-SY5Y Cells: Role Sharing of Two Types of Antioxidative Activities of Melatonin. Biochem. Biophys. Res. Commun., 742.","DOI":"10.1016\/j.bbrc.2024.151074"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"104597","DOI":"10.1016\/j.phrs.2019.104597","article-title":"Melatonin-Sulforaphane Hybrid ITH12674 Attenuates Glial Response in Vivo by Blocking LPS Binding to MD2 and Receptor Oligomerization","volume":"152","author":"Michalska","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.4155\/fmc-2019-0191","article-title":"Synthesis of New Ferulic\/Lipoic\/Comenic Acid-Melatonin Hybrids as Antioxidants and Nrf2 Activators via Ugi Reaction","volume":"11","author":"Martin","year":"2019","journal-title":"Future Med. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Duarte, P., Michalska, P., Crisman, E., Cuadrado, A., and Le\u00f3n, R. (2022). Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson\u2019s Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11020247"},{"key":"ref_134","first-page":"5070","article-title":"Molecular Mechanisms of Melatonin-Induced Alleviation of Synaptic Dysfunction and Neuroinflammation in Parkinson\u2019s Disease: A Review","volume":"27","author":"Guo","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Yousef, O., Abouelmagd, M.E., Khaddam, H., Shbani, A., Yousef, R., Meshref, M., and Hanafi, I. (2025). The Effectiveness of Melatonin for Sleep Disturbances in Parkinson\u2019 Disease: Systematic Review and Meta-Analysis. J. Sleep Res., e70097.","DOI":"10.1111\/jsr.70097"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e095541","DOI":"10.1002\/alz.095541","article-title":"Reevaluating Melatonin\u2019s Efficacy in Alzheimer\u2019s Disease: A 20th-Anniversary Updated Literature Review of Sleep Disturbances and Treatment Trials","volume":"20","author":"Malhotra","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Caneda, C.H., Ant\u00f3n-Fuente, S., P\u00e9rez-Haro, M.J., S\u00e1nchez-Franco, C.M., Alvarez-Rodr\u00edguez, E., Aguado-Valcarcel, M., Marcos-Bobillo, M., Torrente-Carballido, M., and Gonz\u00e1lez-Su\u00e1rez, I. (Neurol. Ther., 2025). Beyond Efficacy: Persistence, NEDA, and Therapeutic Decision-Making in First-Line Multiple Sclerosis Treatment, Neurol. Ther., ahead of print.","DOI":"10.1007\/s40120-025-00811-0"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tips.2023.03.005","article-title":"Omaveloxolone (SkyclarysTM) for Patients with Friedreich\u2019s Ataxia","volume":"44","year":"2023","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/10\/1190\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:21:24Z","timestamp":1759134084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/10\/1190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,28]]},"references-count":138,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["antiox14101190"],"URL":"https:\/\/doi.org\/10.3390\/antiox14101190","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,28]]}}}